Prenatal growth and metabolic syndrome components among Chilean children

F Mardones1, L Villarroel1, P Arnaiz2

  • 11 Department of Public Health, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Insights

Prenatal growth impacts childhood metabolic syndrome (MS) and insulin resistance (IR). Non-optimal fetal development, including birth weight and length, is linked to higher risks of these conditions in children.

Area of Science:

  • Pediatrics
  • Metabolic Health
  • Public Health

Background:

  • The link between prenatal growth and metabolic syndrome (MS) components, including insulin resistance (IR), is understudied in developing nations.
  • Existing data from developed countries show controversial associations between prenatal factors and childhood metabolic health.
  • Understanding these early life origins is crucial for preventing non-communicable diseases.

Purpose of the Study:

  • To investigate the association between prenatal growth parameters (birth weight, length, gestational age) and MS components/IR in Chilean children.
  • To explore potential early life origins of metabolic dysfunction in a developing country context.

Main Methods:

  • A retrospective cohort study involving 2152 children (average age 11.4 years).
  • Data linkage of current metabolic health markers (anthropometry, blood pressure, lipids, glucose, insulin) with historical birth records.
  • Calculation of Homeostasis Model Assessment for Insulin Resistance (HOMA-IR).

Main Results:

  • Prevalence rates: MS 7.6%, IR 24.5%, overweight 34%.
  • Elevated blood pressure showed a negative association with perinatal risk categories.
  • U-shaped associations observed between waist circumference/elevated blood pressure and birth weight/length categories.
  • Inverse associations found between waist circumference and gestational age, blood pressure and gestational age, and HOMA-IR and birth length.

Conclusions:

  • Non-optimal prenatal growth appears to be a risk factor for increased waist circumference, elevated blood pressure, and insulin resistance in school-aged children.
  • These findings support the hypothesis of early life origins for metabolic non-communicable diseases.
  • Observed associations were weak, potentially due to U-shaped relationships and may strengthen with longer follow-up.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8